Member access

4-Traders Homepage  >  Shares  >  Euronext Paris  >  SANOFI    SAN   FR0000120578

SANOFI (SAN)

2580
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Sanofi to Cut 1,500-2,000 Jobs in France - Report

09/15/2012 | 08:11am US/Eastern

French pharmaceutical giant Sanofi SA (SAN.FR, SNY) will disclose cuts of between 1,500 and 2,000 jobs in France on Sept. 25, French newspaper Le Figaro reported Saturday, without citing sources.

The company plans to reduce its 28,000 payroll in France mainly through attrition, the newspaper said.

In July, Sanofi had said it planned to cut jobs at two French units in a bid to preserve the company's profitability, which has been put at risk by recent patent expirations and the economic recession in most of Europe. The company had said it would detail the job cuts in September.

At the time, French Industry Minister Arnaud Montebourg had criticized the company and said he wouldn't tolerate when profitable companies slash jobs.

A Sanofi spokesman didn't return a phone call seeking comments.

Newspaper Web site: http://www.lefigaro.fr

Write to Inti Landauro at inti.landauro@dowjones.com.

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

React to this article
Latest news on SANOFI
10:33a SANOFI : INVESTOR ALERT: Law Offices of Howard G. Smith Announces Lead Plaintiff..
01/27DJAmgen Profit Rises 27% on Higher Sales of Key Drugs -- Update
01/27 SANOFI : and Regeneron Announce Praluent (alirocumab) Biologics License Applicat..
01/27 Baiyunshan, Siemens to March into Medical Devices
01/26 ALNYLAM PHARMACEUTICALS : Entry into a Material Definitive Agreement, Unregister..
01/26DJSANOFI : FDA Grants Priority Review for Sanofi and Regeneron's Drug
01/26 SANOFI : Regeneron and Sanofi Announce Praluent(TM) (alirocumab) Biologics Licen..
01/26 SANOFI : : and Regeneron Announce Praluent(TM) (alirocumab) Biologics License Ap..
01/23 GENZYME : Reports Findings in Molecular Genetics (SMN regulates axonal local tra..
01/23 GENZYME : Cerdelga gets European marketing authorization for Gaucher Disease
Advertisement
Chart
Duration : Period :
SANOFI Technical Analysis Chart | SAN | FR0000120578 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF